Navigation Links
Vaccine Made from Live bird flu virus vaccine Offers Protection to Animals

According to US researchers three experimental vaccines using live but weakened versions of the H5N1 bird flu virus seemed to offer protection against infection//, and could probably be the solution to to stockpile vaccines ahead of a pandemic.

They said tests on people were already underway, and this could lead to the start of a repository of vaccines against various potential strains of pandemic influenza.

The researchers wrote in the online journal Public Library of Science-Medicine, "We have been developing live, attenuated influenza virus vaccines because they have properties that make them attractive vaccines for the prevention of pandemic influenza in humans."

This vaccine takes only a single dose of a live, weakened vaccine to stimulate a good immune response according to researchers.

Another advantage that lay with such vaccines is the benefit of cross-protection, which meant that the vaccine protects against other, similar strains of the virus. This was useful especially because the current flu mutates a little every year, forcing vaccine makers to reformulate annually.

Director of National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci said, "If an influenza pandemic were imminent or underway, we would need a vaccine that could stimulate immunity quickly, preferably with a single dose."

Health experts fear a mutation of the H5N1 avian flu virus that is now killing birds globally, into a form that easily infects people, sparking a pandemic that could kill millions.

Although H5N1 has infected only 244 people and killed 143, governments, companies and other organizations are racing to produce a vaccine.

So far the vaccines that have been developed use pieces of DNA from the viruses while some others use a virus that is completely inactivated, or killed. Since most seasonal flu vaccines use a killed virus there is little chances of cross-pr otection.

Maryland-based MedImmune Inc has engineered a live but weakened virus that is delivered as a nasal spray instead of injected by needle.

Researchers from MedImmune worked with teams at the National Institutes of Health and the U.S. Department of Agriculture to make a live H5N1 vaccine. The teams were led by Dr. Kanta Subbarao of NIAID using three different strains of H5N1 dating back to when the dangerous form first emerged in Hong Kong in 1997.

The researchers reported that mice that got a single dose of vaccine, given in a nose spray, all survived normally lethal doses of H5N1. It was found that mice and ferrets given two doses of vaccine were not only protected but that their bodies also suppressed the virus.

The team artificially constructed their viruses using weakened flu strains and added key proteins from H5N1 strains that infected people in 1997,2003 and 2004.

Even more amazing was the usual low-tech approach to produce this vaccine, growing it in chicken eggs, that is in the same way that seasonal flu vaccine is produced.

MedImmune said in June it was already testing one of the vaccines in human volunteers, in what is known as a Phase I safety trial.

The researchers noted it is not possible to predict which strain of H5N1 or any other influenza virus might cause a pandemic. There are hundreds of different possible combinations of hemagglutinin (the "H" in a flu strain's name) and neuraminidase (the "N").

The researchers wrote, "If the vaccine candidates described in this paper elicit a broadly cross-reactive protective immune response in humans, they would support the approach of developing one or two pandemic vaccine candidates for each subtype (H4 through H16) …."


NLA
'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2017)... ... June 24, 2017 , ... ... Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and ... so that visits to the dentist fit into their patients’ busy lifestyles. Dental365 ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... the launch of Care Management Alerts and Dashboards, an innovative new service enabling ... Island. , RIQI’s Care Management Alerts and Dashboards provide near real-time data about ...
(Date:6/23/2017)... ... 2017 , ... Yesterday, U.S. Senate Republicans revealed details of ... replace the Affordable Care Act (ACA). Like the bill narrowly passed by the ... public health insurance program for low-income children, pregnant women, parents of dependent children, ...
(Date:6/23/2017)... ... 2017 , ... Dr. Ran Y. Rubinstein , a ... offering three new minimally invasive procedures to patients who want a younger and ... Rubinstein is excited to bring microneedling, microneedling facials, and platelet rich plasma (PRP) ...
(Date:6/23/2017)... ... ... Goodcents Deli Fresh Subs today announced the opening of a new restaurant in ... Kan. 66604 (near 21st and Gage). It is owned and operated by long-time Goodcents ... the Topeka and Bonner Springs, Kan. area. , “Goodcents has such a loyal ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... Fla. , June 8, 2017  Less than ... that hit more than 200,000 companies, including hospital networks, ... being heralded as one of the largest online extortion ... in the healthcare market, it is imperative that providers ... protect their data from this — and many other ...
(Date:6/7/2017)... 2017  Diplomat Specialty Infusion Group, a brand of Diplomat Pharmacy, ... Iowa location. The ... features an ISO 7 cleanroom—the standard needed to compound intravenous (IV) ... level of pollutants. "Our new ... better serve our Iowa patients," said ...
(Date:6/1/2017)... BLUE BELL, Pa. , June 1, 2017 /PRNewswire/ ... Nutriceuticals (PRN) and Veterinarian Recommended Solutions (VRS), and KD ... direct investment in Nutriceutical Holdings by KD Pharma Group. ... Nutriceutical Holdings with the option to acquire the entire ... ideal partner in KD. They are committed to growing ...
Breaking Medicine Technology: